Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Hemoglobin is Scopus-indexed (Q3, CiteScore 1.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0363-0269Verify ISSN ↗1532-432XVerify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 100 / 151 | 34th | Q3 |
| Biochemistry (medical) | 55 / 78 | 30th | Q3 |
| Genetics (clinical) | 80 / 100 | 20th | Q4 |
| Clinical Biochemistry | 105 / 124 | 15th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1976–present, best quartile Q3, CiteScore 1.8.
Hemoglobin is Q3 in Hematology (rank 100 of 151), Q3 in Biochemistry (medical) (rank 55 of 78) and Q4 in Genetics (clinical) (rank 80 of 100), by CiteScore 2025. It is ranked in 4 subject areas in all.
Hemoglobin is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.8, which places it in quartile Q3 at the 34th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.311, quartile Q3, with an H-index of 48.
Hemoglobin is published by Taylor and Francis Ltd. Its print ISSN is 0363-0269 and its online ISSN is 1532-432X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Hemoglobin has an h-index of 60 and a 2-year mean of 0.76 citations per paper (OpenAlex). Its Scopus CiteScore is 1.8, quartile Q3. On 2-year citations it ranks #103 of 148 Scopus journals in Hematology.
Hemoglobin published 75 papers in 2025; its busiest recent year was 2019 with 130. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from China (22.4%), India (11.2%) and Türkiye (7.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.